Mastic Tree Resin

Mastic tree resin contains over 120 bioactive compounds including triterpenes like masticadienonic acid and oleanolic acid that suppress the NF-κB inflammatory pathway. The resin demonstrates antimicrobial activity against H. pylori and reduces pro-inflammatory cytokines TNF-α, IL-1β, and IL-6.

Origin & History

Mastic Tree Resin (Pistacia lentiscus var. chia) is exclusively sourced from the mastic trees thriving on the Greek island of Chios, and also found in other Eastern Mediterranean regions like Turkey and North Africa. It flourishes in rocky, sun-drenched, well-drained soils, yielding a unique aromatic resin.

Historical & Cultural Context

Mastic resin has been used for over 2,500 years in Greek, Arabic, and Mediterranean medicine. Traditionally, it was chewed to freshen breath and ease digestion, decocted for ulcers and wounds, and burned ceremonially for purification.

Health Benefits

- Supports gastrointestinal health by inhibiting Helicobacter pylori and reducing inflammation.
- Promotes oral hygiene by reducing plaque formation and bacterial growth.
- Aids in digestive wellness by soothing stomach discomfort and supporting gut lining integrity.
- Provides anti-inflammatory effects, particularly in the gastrointestinal tract.
- Contributes to respiratory support by modulating mucosal responses.

How It Works

Mastic resin's triterpenes including masticadienonic acid and oleanolic acid suppress the NF-κB pathway, reducing pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 while promoting anti-inflammatory M2 macrophage polarization. The monoterpenes alpha-pinene and beta-pinene provide antioxidant effects by upregulating NRF2, SOD1, and GPX1 genes. In cancer cells, these compounds trigger apoptosis through caspase activation and androgen receptor inhibition.

Scientific Research

Numerous clinical studies and in vitro research, as found in PubMed and ScienceDirect, demonstrate Mastic resin's efficacy against Helicobacter pylori and its benefits for gastrointestinal health. Evidence also supports its role in oral hygiene and anti-inflammatory processes.

Clinical Summary

Clinical evidence for mastic resin remains limited with most research consisting of in vitro and animal studies rather than large-scale human trials. One human cohort study showed reduced TNF-α secretion in monocytes, though specific sample sizes were not reported. In vitro cytotoxicity studies demonstrated IC50 values of 14.76-18.05 µg/mL against pancreatic cancer cells, outperforming doxorubicin. No large randomized controlled trials with quantified H. pylori eradication rates or digestive health outcomes have been published, indicating the need for more robust clinical research.

Nutritional Profile

- Triterpenic Acids: Including masticadienonic and isomasticadienonic acids, key for its therapeutic effects.
- Terpenes: Alpha-pinene, beta-myrcene, linalool, and verbenone, contributing to its aromatic profile.
- Polyphenols and Resin Acids: Providing antioxidant and anti-inflammatory properties.
- Minerals: Trace amounts of zinc and copper, supporting enzymatic functions.

Preparation & Dosage

- Commonly consumed as resin powder or chewed as a pea-sized piece.
- Can be used topically in oils or balms for skin applications.
- Recommended dosage: 350–1,000 mg/day of resin powder for digestive and oral health.

Synergy & Pairings

Role: Resin botanical
Intention: Gut & Microbiome
Primary Pairings: - Licorice Root (Glycyrrhiza glabra)
- Slippery Elm (Ulmus rubra)
- Milk Thistle (Silybum marianum)
- Peppermint (Mentha piperita)

Safety & Interactions

Mastic resin is generally well-tolerated with low toxicity and no major safety issues reported in available studies. In vitro research shows dose-dependent reduction in cell viability through mitochondrial apoptosis, though human equivalent doses remain unclear. No specific drug interactions or contraindications are documented, though the liver-metabolized triterpenes may potentially affect phase I/II biotransformation pathways. While early research suggests hepatoprotective properties, patients with liver disease should be monitored, and safety during pregnancy and breastfeeding has not been established.